Formulation and evaluation of cholesterol-rich nanoemulsion (LDE) for drug delivery potential of cholesteryl-maleoyl-5-fluorouracil

References

• Rossella P, Massimo B, Simona G, Christopher AJ. Hydrophilic interaction liquid chromatography–APCI–mass spectrometry determination of 5-fluorouracil in plasma and tissues. J Pharm Biomed Anal 2005;38:738–745
   PubMed Web of Science ®Google Scholar
• Dong Z, Zheng W, Xu Z, Yin Z. Improved stability and tumor targeting of 5-fluorouracil by conjugation with hyaluronan. J Appl Polym Sci 2013;130:927–932
   Web of Science ®Google Scholar
• Presant CA, Jacobson J, Wolf W, et al. Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil? A Southwest oncology group study. Invest New Drugs 2002;20:369–376
   PubMed Web of Science ®Google Scholar
• Longley DB, Harkin DP, Johnston PG. Reviews and comments from the nature publishing group. Nat Rev Cancer 2003;3:330
   PubMed Web of Science ®Google Scholar
• Koukourakis GV, Kouloulias V, Koukourakis MJ, et al. Efficacy of the oral fluorouracil prodrug capecitabine in cancer treatment: a review. Molecules 2008;13:1897–1922
   PubMed Web of Science ®Google Scholar
• Kuzuhara S, Ohkoshi N, Kanemaru K, et al. Subacute leucoencephalopathy induced by carmofur, a 5f-fluorouracil derivative. Neurology 1987;234:365–370
   Web of Science ®Google Scholar
• Casado E, Pfeiffer P, Feliu J, et al. UFT (tegafur uracil) in rectal cancer. Ann Oncol 2008;19:1371–1378
   PubMedGoogle Scholar
• Cosco D, Paolino D, Muzzalupo R, et al. Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil. Biomed Microdevices 2009;11:1115–1125
   PubMed Web of Science ®Google Scholar
• Gupta RR, Jain SK, Varshney M. AOT water-in-oil microemulsions as a potential enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surf B 2005;41:25–32
   PubMed Web of Science ®Google Scholar
• Li S, Wang A, Jiang W, Guan Z. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. BMC Cancer 2008;8:E103
   PubMed Web of Science ®Google Scholar
• Lin Y, Li Y, Ooi CP. 5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy. J Mater Sci Mater Med 2012;23:2453–2460
   PubMed Web of Science ®Google Scholar
• Ahmad MZ, Akhtar S, Anwar M, Ahmad FJ. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer. Mol Pharm 2012;9:2986–2994
   PubMed Web of Science ®Google Scholar
• Ashwanikumar N, Kumar NA, Nair SA, Kumar GV. Methacrylic-based nanogels for the pH-sensitive delivery of 5-fluorouracil in the colon. Int J Nanomed 2012;7:5769–5779
   PubMed Web of Science ®Google Scholar
• Shishu K, Maheshwari M. Development and evaluation of novel microemulsion based oral formulations of 5-fluorouracil using non-everted rat intestine sac model. Drug Dev Ind Pharm 2012;38:294–300
   PubMed Web of Science ®Google Scholar
• Thomas AM, Kapanen AI, Hare JI, et al. Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy. J Controlled Release 2011;150:212–219
   PubMed Web of Science ®Google Scholar
• Yanyu X, Fang L, Qineng P, Hao C. The influence of the structure and the composition of water/AOT-Tween 85/IPM microemulsion system on transdermal delivery of 5-fluorouracil. Drug Dev Ind Pharm 2012;38:1521–1529
   PubMed Web of Science ®Google Scholar
• Yassin AEB, Anwer MK, Mowafy HA, et al. Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. Int J Med Sci 2010;7:398–408
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wo Y, Zhang Y, et al. In vitro study of ethosome penetration in human skin and hypertrophic scar tissue. Nanomedicine 2012;8:1026–1033
   PubMed Web of Science ®Google Scholar
• Valduga CJ, Fernandes DC, Lo Prete AC, et al. Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide. J Pharm Pharmacol 2003;55:1615–1622
   PubMed Web of Science ®Google Scholar
• Moura JA, Valduga CJ, Tavares ER, et al. Novel formulation of a methotrexate derivative with a lipid nanoemulsion. Int J Nanomed 2011;6:2285–2265
   PubMed Web of Science ®Google Scholar
• Maranhão RC, César TB, Pedroso-Mariani SR, et al. Metabolic behavior in rats of a non-protein microemulsion resembling low density lipoprotein. Lipids 1993;28:691–696
   PubMed Web of Science ®Google Scholar
• Ades A, Carvalho JP, Graziani SR, et al. Uptake of a cholesterol rich emulsion by neoplastic ovarian tissues. Gynecol Oncol 2001;81:84–87
   Google Scholar
• Graziani SR, Igreja FAF, Hegg R, et al. Uptake of a cholesterol-rich emulsion by breast cancer. Gynecol Oncol 2002;85:493–497
   PubMed Web of Science ®Google Scholar
• Azevedo CH, Carvalho JP, Valduga CJ, Maranhão RC. Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinoma. Gynecol Oncol 2005;97:178–182
   PubMed Web of Science ®Google Scholar
• Rodrigues DG, Maria DA, Fernandes DC, et al. Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies. Cancer Chemother Pharmacol 2005;55:565–576
   PubMed Web of Science ®Google Scholar
• Dias ML, Carvalho JP, Rodrigues DG, et al. Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers. Cancer Chemother Pharmacol 2007;59:105–111
   PubMed Web of Science ®Google Scholar
• Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 2007;66:227–243
   PubMed Web of Science ®Google Scholar
• Shakeel F, Haq N, Elbadry M, et al. Ultra fine super self-nanoemulsifying drug delivery system enhanced solubility and dissolution of indomethacin. J Mol Liq 2013;180:89–94
   Web of Science ®Google Scholar
• Bali V, Ali M, Ali J. Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamics, pharmacokinetic and stability assessment. Int J Pharm 2011;403:46–56
   PubMed Web of Science ®Google Scholar
• Villar AM, Naveros BC, Campmany AC, et al. Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil. Int J Pharm 2012;431:161–175
   PubMed Web of Science ®Google Scholar